Decheng Capital

Status

ACTIVE

Global HQ

Silicon Valley, United States

Countries of investment

USA
China

Investment stages

Pre-Seed
Seed
Series A
Series B

Industries

Health Tech
Biotechnology

About
Decheng Capital is a leading venture capital firm specializing in investments in early and growth stage life science companies across China. With a strong focus on fostering innovative technologies, Decheng Capital provides not only capital but also strategic support to help its portfolio companies thrive in the competitive healthcare landscape. The firm is committed to enhancing market presence and driving advancements that contribute to the overall improvement of healthcare outcomes. Through its extensive industry expertise and network, Decheng Capital aims to empower visionary entrepreneurs and transform groundbreaking ideas into impactful realities.

Min check size: $500K
Max check size: $10M
Fund size: Unlock
NPS: Unlock

Investment Thesis

Decheng Capital provides capital and strategic support to early stage life science companies with revolutionary technologies and growth stage healthcare companies with strong market presence.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

Bringing extensive expertise in technology and healthcare investments, the fund manager has executed over 30 significant deals across North America and Asia. Leveraging a data-driven approach, they focus on early to growth-stage companies, emphasizing thematic trends within the market. Their strategic style prioritizes operational excellence, which has led to notable exits that consistently exceed industry benchmarks. Engaging with innovative startups, they aim to drive value creation through hands-on support and strategic insights.